Interesting T2DM: Pharmacotherapy & Obesity Outcomes

April 12, 2017

Our April list includes CV events with DPP-4 or SGLT2 inhibitors vs. insulin, and impact of obesity on nonalcoholic fatty liver disease and thyroid function.

We present a selection of interesting endocrinology articles for the month of April in the following slides. See the slide legends for links to the article summaries.